Harbor Investment Advisory’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.4M | Sell |
2,675
-523
| -16% | -$275K | 0.13% | 133 |
|
|
2025
Q1 | $2.03M | Sell |
3,198
-414
| -11% | -$263K | 0.2% | 91 |
|
|
2024
Q4 | $2.57M | Sell |
3,612
-52
| -1% | -$37K | 0.24% | 78 |
|
|
2024
Q3 | $3.85M | Sell |
3,664
-100
| -3% | -$105K | 0.38% | 52 |
|
|
2024
Q2 | $3.96M | Buy |
3,764
+56
| +2% | +$58.9K | 0.41% | 44 |
|
|
2024
Q1 | $3.57M | Buy |
3,708
+35
| +1% | +$33.7K | 0.37% | 53 |
|
|
2023
Q4 | $3.23M | Buy |
3,673
+50
| +1% | +$43.9K | 0.37% | 54 |
|
|
2023
Q3 | $2.98M | Sell |
3,623
-5
| -0.1% | -$4.12K | 0.39% | 51 |
|
|
2023
Q2 | $2.61M | Hold |
3,628
| – | – | 0.36% | 60 |
|
|
2023
Q1 | $2.98M | Sell |
3,628
-400
| -10% | -$329K | 0.45% | 51 |
|
|
2022
Q4 | $2.91M | Sell |
4,028
-50
| -1% | -$36.1K | 0.45% | 54 |
|
|
2022
Q3 | $2.81M | Sell |
4,078
-313
| -7% | -$216K | 0.46% | 47 |
|
|
2022
Q2 | $2.6M | Sell |
4,391
-344
| -7% | -$203K | 0.42% | 52 |
|
|
2022
Q1 | $3.31M | Buy |
4,735
+112
| +2% | +$78.2K | 0.44% | 48 |
|
|
2021
Q4 | $2.92M | Sell |
4,623
-266
| -5% | -$168K | 0.37% | 53 |
|
|
2021
Q3 | $2.96M | Buy |
4,889
+145
| +3% | +$87.8K | 0.4% | 51 |
|
|
2021
Q2 | $2.65M | Buy |
4,744
+516
| +12% | +$288K | 0.36% | 59 |
|
|
2021
Q1 | $2M | Buy |
4,228
+460
| +12% | +$218K | 0.3% | 70 |
|
|
2020
Q4 | $1.82M | Buy |
3,768
+2,823
| +299% | +$1.36M | 0.29% | 71 |
|
|
2020
Q3 | $529K | Buy |
945
+119
| +14% | +$66.6K | 0.1% | 159 |
|
|
2020
Q2 | $515K | Buy |
826
+24
| +3% | +$15K | 0.11% | 150 |
|
|
2020
Q1 | $392K | Buy |
802
+87
| +12% | +$42.5K | 0.11% | 153 |
|
|
2019
Q4 | $268K | Buy |
+715
| New | +$268K | 0.06% | 216 |
|